Jason P Rhodes - Net Worth and Insider Trading

Jason P Rhodes Net Worth

The estimated net worth of Jason P Rhodes is at least $244 Million dollars as of 2024-04-23. Jason P Rhodes is the Director of Dyne Therapeutics Inc and owns about 8,050,704 shares of Dyne Therapeutics Inc (DYN) stock worth over $200 Million. Jason P Rhodes is the Director of Generation Bio Co and owns about 8,279,484 shares of Generation Bio Co (GBIO) stock worth over $23 Million. Jason P Rhodes is also the Director of Replimune Group Inc and owns about 3,228,912 shares of Replimune Group Inc (REPL) stock worth over $21 Million. Details can be seen in Jason P Rhodes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason P Rhodes has not made any transactions after 2024-02-28 and currently still holds the listed stock(s).

Transaction Summary of Jason P Rhodes

To

Jason P Rhodes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason P Rhodes owns 5 companies in total, including Dyne Therapeutics Inc (DYN) , Generation Bio Co (GBIO) , and Replimune Group Inc (REPL) among others .

Click here to see the complete history of Jason P Rhodes’s form 4 insider trades.

Insider Ownership Summary of Jason P Rhodes

Ticker Comapny Transaction Date Type of Owner
DYN Dyne Therapeutics Inc 2024-02-28 director & 10 percent owner
GBIO Generation Bio Co 2021-09-29 director
REPL Replimune Group Inc 2021-01-26 director
EPZM Epizyme Inc 2013-05-30 10 percent owner & EVP & CFO and Treasurer
IRON Disc Medicine Inc 2021-10-04 director & 10 percent owner

Jason P Rhodes Latest Holdings Summary

Jason P Rhodes currently owns a total of 3 stocks. Among these stocks, Jason P Rhodes owns 8,050,704 shares of Dyne Therapeutics Inc (DYN) as of February 28, 2024, with a value of $200 Million and a weighting of 82.01%. Jason P Rhodes owns 8,279,484 shares of Generation Bio Co (GBIO) as of September 29, 2021, with a value of $23 Million and a weighting of 9.5%. Jason P Rhodes also owns 3,228,912 shares of Replimune Group Inc (REPL) as of January 26, 2021, with a value of $21 Million and a weighting of 8.49%.

Latest Holdings of Jason P Rhodes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DYN Dyne Therapeutics Inc 2024-02-28 8,050,704 24.87 200,221,008
GBIO Generation Bio Co 2021-09-29 8,279,484 2.80 23,182,555
REPL Replimune Group Inc 2021-01-26 3,228,912 6.42 20,729,615

Holding Weightings of Jason P Rhodes


Jason P Rhodes Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason P Rhodes has made a total of 4 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 807,838 shares on February 28, 2024, which brought Jason P Rhodes around $20 Million.

According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Generation Bio Co (GBIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Generation Bio Co is the sale of 81,088 shares on September 29, 2021, which brought Jason P Rhodes around $2 Million.

According to the SEC Form 4 filings, Jason P Rhodes has made a total of 6 transactions in Replimune Group Inc (REPL) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Replimune Group Inc is the sale of 5,558 shares on January 26, 2021, which brought Jason P Rhodes around $256,446.

Insider Trading History of Jason P Rhodes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason P Rhodes Trading Performance

GuruFocus tracks the stock performance after each of Jason P Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason P Rhodes is 26.97%. GuruFocus also compares Jason P Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason P Rhodes within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jason P Rhodes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jason P Rhodes

Average Return

150.24%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.76 26.97 42.67 150.24 67.33 16.83
Relative Return to S&P 500(%) 10.75 24.61 41 134.94 44.61 8.54

Jason P Rhodes Ownership Network

Ownership Network List of Jason P Rhodes

No Data

Ownership Network Relation of Jason P Rhodes


Jason P Rhodes Owned Company Details

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Jason P Rhodes is the director & 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include Chief Medical Officer Wildon Farwell , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Jason P Rhodes made 4 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 884,198. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 1,171,794 shares made by Joshua T Brumm .

In summary, during the past 3 months, insiders sold 4,554,480 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,554,480 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyne Therapeutics Inc Insider Transactions

No Available Data

Jason P Rhodes Mailing Address

Above is the net worth, insider trading, and ownership report for Jason P Rhodes. You might contact Jason P Rhodes via mailing address: C/o Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge Ma 02139.

Discussions on Jason P Rhodes

No discussions yet.